
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies has over 25 years’ combined experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules expressed in a wide array of microbial, mammalian, and insect systems. The company offers a comprehensive list of services from cell line development, including its proprietary pAVEway™ system, to process development, analytical development, clinical and commercial manufacturing. Both sites are FDA-approved for the production of commercial products.